论文部分内容阅读
目的观察思连康在辅助治疗慢性盆腔炎继发腹泻过程中的临床效果。方法将238例患者分成治疗组和对照组,治疗组119例患者,予头孢哌酮钠+思连康,对照组119例患者,单独予头孢哌酮钠,两组患者均按慢性盆腔炎急性发作治疗方案应用抗生素以及对症处理等常规治疗。结果治疗组无腹泻发生患者为96例(80.7%),与对照组68例(57.14%)无腹泻发生比较,差异显著(P<0.01);腹泻程度差异显著(P<0.01)。结论思连康是微生态调节剂,具有调节菌群平衡,抑制肠道内致病菌生长的作用,预防慢性盆腔炎急性发作继发腹泻有很好疗效,值得临床推广应用。
Objective To observe the clinical effect of Si Lian Kang in adjuvant treatment of secondary diarrhea due to chronic pelvic inflammatory disease. Methods A total of 238 patients were divided into treatment group and control group. One hundred and ninety-nine patients in the treatment group were treated with Cefoperazone sodium and Si Liankang, and 119 patients in the control group were treated with cefoperazone sodium alone. Both groups were given antibiotics according to the acute attack of chronic pelvic inflammatory disease and Symptomatic treatment and other conventional treatment. Results There were 96 cases (80.7%) in the treatment group without diarrhea and 68 cases (57.14%) in the control group without diarrhea. The difference was significant (P <0.01). Conclusion Si Liankang is a microecological regulator, with the regulation of flora balance, inhibit the growth of pathogenic bacteria in the gut, prevention of acute pelvic inflammatory disease secondary to diarrhea have a good effect, it is worthy of clinical application.